Login

Mike Speetzen, CEO of Polaris, joins 'Closing Bell: Overtime' to discuss investor day, earnings, and the state of the high-ticket consumer market. 00:10:00

Share On Facebook Share On Twitter

Marc Murnaghan - Polaris Renewable Energy Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
PYX Resources: Leading the Global Mineral Sands Market
00:10:00
Exploring Kirkland Lake's Rich Mining History and Promising New Drilling Targets
00:10:00
focused exclusively on funding entrepreneurs|Evan Baehr,Managing Partner,Learn Capital
00:10:00
London's Modern Art Gallery Expands Central and Eastern Europe Collection|Jan Hammer,partner,Index Ventures
00:10:00
Fueling Growth: HR, Talent, and Culture in the Startup Ecosystem | Paul J. Sarvadi - CEO & Chairman of Insperity, Inc.
00:10:00
Investment Banking Technicals Mock Interview with Ziad and Devon | EarlyAdmit
00:10:00
South African Diamond Mining Firm Explores Near-Term Production Opportunities at One-to-One Mining Conference
00:10:00
Keith Muller, CEO of Atlantic Lithium, Discusses Ewoyaa Project and Future Plans
00:10:00
Strategizing for 2022: Insights Live on Navigating Credit Market Headwinds with Bruce Karsh, Armen Panossian, and Danielle Poli
00:10:00
Goldman Sachs 2020 Investor Day: Strategic Priorities and Shareholder Value Focus
00:10:00
Stan Lib's Economic Forecast: Navigating Political Risks and Growth Trajectories in 2017 | Kevin Lings, Chief Economist , STANLIB Wealth Management.
00:10:00
In this video, CEO Tobias Hartmann and CFO Dirk Schmelzer provide insights into Scout24's preliminary results for 2023.

© 2017 - Neuhu+